Invesaro

Stocks Health care XRAY

NASDAQ · Health care

DENTSPLY SIRONA Inc. (XRAY)

DENTSPLY SIRONA Inc. brought in $3.6B of revenue over the twelve months to September 30, 2026, down 1.4% from a year earlier. It posted a net loss of $121M. Operating cash flow minus capital spending left $104M of free cash flow in fiscal 2025. At September 30, 2026 it held $195M in cash against $2B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 5, 2026.

Free, no password. An email when XRAY files with the SEC.

Price
$9.70
+1.68% on the day · November 10, 2026
52-week range $8.14 to $14.76
Market cap
$1.9B
Revenue (last 12 months)
$3.6B
-1.4% year on year
Net margin
-3.4%

Key facts about DENTSPLY SIRONA Inc.

Net worth
DENTSPLY SIRONA Inc. has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $1.4B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $3.7B (-3.0% year on year), with a net loss of $598M. Over the 12 months to September 30, 2026: revenue $3.6B, net loss $121M.
Cash flow
In fiscal 2025 operations brought in $235M of cash; after $131M of capital spending, free cash flow was $104M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 5, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
DENTSPLY SIRONA Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.
Dividend
DENTSPLY SIRONA Inc. declared dividends of $0.64 per share in fiscal 2025, a yield of 6.60% at the current price.

What DENTSPLY SIRONA Inc. does

DENTSPLY SIRONA Inc. is registered with the SEC under industry code SIC 3843 (Dental Equipment & Supplies). Its shares trade on NASDAQ under the ticker XRAY.

Revenue and profit by year

Revenue
FY18: $4B $4B FY18FY19: $4B $4B FY19FY20: $3.3B $3.3B FY20FY21: $4.2B $4.2B FY21FY22: $3.9B $3.9B FY22FY23: $4B $4B FY23FY24: $3.8B $3.8B FY24FY25: $3.7B $3.7B FY25
Net income
FY18: -$1B -$1B FY18FY19: $256M $256M FY19FY20: -$73M -$73M FY20FY21: $411M $411M FY21FY22: -$950M -$950M FY22FY23: -$132M -$132M FY23FY24: -$910M -$910M FY24FY25: -$598M -$598M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$3.7B-$422M-$598M-$3.00$104M
2024$3.8B-$879M-$910M-$4.48$281M
2023$4B-$85M-$132M-$0.62$228M
2022$3.9B-$937M-$950M-$4.41$368M
2021$4.2B$608M$411M$1.87$515M
2020$3.3B-$3M-$73M-$0.33$562M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 25, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 26, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where XRAY ranks in Health care

Revenue$3.7B
#82 of 751 in Health care · Top 11%
Revenue growth-3.0%
#439 of 532 in Health care · Bottom 18%
Net margin-16.3%
#309 of 544 in Health care · Bottom 43%
Free cash flow margin2.8%
#212 of 490 in Health care · Top 43%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Dividends

DENTSPLY SIRONA Inc. declared $0.64 per share in fiscal 2025. At the current price that is a yield of 6.60%. It paid out $128M in cash dividends.

Fiscal yearPer sharePaid outOf profit
2025$0.64$128Mn/a
2024$0.64$126Mn/a
2023$0.56$116Mn/a
2022$0.50$104Mn/a
2021$0.43$92M22%
2020$0.40$88Mn/a

Per share as declared (or paid, where only that is reported), adjusted for stock splits the company itself restated. Yield is the latest fiscal year's dividend over the current price.

Latest SEC filings

What DENTSPLY SIRONA Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 5, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue fell 7.5% to $836M versus the same quarter last year; diluted EPS -$0.01 versus -$2.14.
  2. November 5, 2026
  3. October 9, 2026
    Material agreement8-KDENTSPLY SIRONA amended its revolving credit facility and note purchase agreements to adjust debt covenant terms.
  4. August 14, 2026
  5. August 13, 2026
  6. August 7, 2026
  7. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue fell 4.1% to $898M versus the same quarter last year; diluted EPS $0.18 versus -$0.22.
  8. August 6, 2026
  9. August 6, 2026
  10. July 8, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on October 2, 2026. Insider transactions on SEC

What is XRAY worth? A DCF from its reported cash flow

Insider trades

What the people running DENTSPLY SIRONA Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

Bought (open market)
$0
last 90 days
Sold
$0
last 90 days
DateInsiderWhatSharesPriceValueFiling
August 10, 2026 Fortson John C.EVP & CFO Received as pay 24,014 - - Form 4
August 7, 2026 Frohning Andrea L.SVP, CHRO Shares withheld for tax 802 $12.12 $9.7K Form 4
June 15, 2026 Hosein ClydeDirector Bought 6,500 $9.99 $64.9K Form 4
June 15, 2026 Gladden Brian TDirector Bought 9,985 $10.02 $100K Form 4
June 12, 2026 Mazelsky Jonathan JayDirector Bought 10,000 $10.14 $101.4K Form 4
June 12, 2026 Mckeon Brian PDirector Boughtindirect 10,000 $10.12 $101.2K Form 4
June 11, 2026 Barber Michael JDirector Bought 15,175 $9.89 $150K Form 4
June 11, 2026 Holden Betsy DDirector Bought 10,086 $9.88 $99.7K Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns XRAY

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Vanguard Portfolio Management13G, passive 5.36% 10,724,505 April 29, 2026
Vanguard Capital Management13G, passive 5.27% 10,529,427 April 29, 2026
AQR Capital Management, LLC13G, passive with 1 related filers 5.22% 10,458,771 August 13, 2026

Latest filings below 5%: Southpoint Master Fund, LP 3.5% (August 14, 2026); First Eagle Investment Management, LLC 0.4% (August 6, 2026); The Vanguard Group 0% (March 26, 2026); Lazard Asset Management LLC 4.4% (February 17, 2026); T. Rowe Price Associates, Inc. 0.1% (November 14, 2025).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 373 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.26,711,079$283.4M+7,459,210
Fuller & Thaler Asset Management, Inc.12,697,269$134.7M-95,249
Vanguard Portfolio Management LLC11,779,851$125M+1,249,105
Aqr Capital Management LLC10,458,771$110.2M+6,493,548
State Street Corp9,285,298$98.5M+2,040,461
Vanguard Capital Management LLC9,047,628$96M+48,071
Lazard Asset Management LLC8,269,867$87.7M+1,554,104
Ariel Investments, LLC8,026,107$85.2M+1,639,292
Southpoint Capital Advisors LP7,000,000$74.3M-3,000,000
Cooke & Bieler LP6,927,915$73.5M-873,272
Geode Capital Management, LLC5,650,605$60M+1,826,968
Invenomic Capital Management LP4,909,808$52.1M+519,715
Edmond DE Rothschild Holding S.A.4,503,300$47.8M+325,000
Jupiter Asset Management Ltd4,495,136$47.7M+3,688,171
Allianz Asset Management GmbH3,823,808$40.6M+877,624
Marshall Wace, Llp3,800,116$40.3M-708,286
Paradigm Capital Management Inc3,748,800$39.8M+771,600
Armistice Capital, LLC3,672,000$39M+672,000
Dimensional Fund Advisors LP3,460,636$36.7M-98,752
D. E. Shaw & Co., Inc.2,987,178$31.7M+554,459

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

18 insiders reported holding 1,221,321 shares in total, about $11.8M at the last price.

HolderSharesAs of
Johnson Robert AnthonySVP, Chief Supply Chain Office 161,819 March 4, 2026
Scavilla Daniel TPresident, CEO & Member of BOD, Director 157,754 May 22, 2026
Holden Betsy DDirector 87,528 June 11, 2026
Varon Leslie FDirector 80,364 June 3, 2026
Hosein ClydeDirector 70,575 June 15, 2026
Vergis Janet S.Director 67,324 June 3, 2026
Lucier Gregory TDirector 63,28363,283 held indirectly June 3, 2026
Frohning Andrea L.SVP, CHRO 63,191 August 7, 2026
Gladden Brian TDirector 61,849 June 15, 2026
Mazelsky Jonathan JayDirector 61,669 June 12, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about XRAY

What does DENTSPLY SIRONA Inc. do?

DENTSPLY SIRONA Inc. is a company in the Health care sector, listed on NASDAQ as XRAY. Its shares trade on NASDAQ under the ticker XRAY.

What is DENTSPLY SIRONA Inc.'s net worth?

DENTSPLY SIRONA Inc. has a market value (market cap) of $1.9B at the latest share price, and shareholders' equity of $1.4B on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is DENTSPLY SIRONA Inc. profitable?

No. Over the twelve months to September 30, 2026 it reported a net loss of $121M on revenue of $3.6B.

How much revenue does DENTSPLY SIRONA Inc. make?

Over the twelve months to September 30, 2026 DENTSPLY SIRONA Inc. reported revenue of $3.6B. That is 1.4% less than a year earlier.

When did DENTSPLY SIRONA Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 5, 2026. It covers the period to September 30, 2026.

When is DENTSPLY SIRONA Inc.'s next earnings report?

DENTSPLY SIRONA Inc.'s next report is expected around February 25, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Does DENTSPLY SIRONA Inc. pay a dividend?

Yes. DENTSPLY SIRONA Inc. declared dividends of $0.64 per share in fiscal 2025, a yield of 6.60% at the current price.

Similar companies

Compare XRAY with

Compare XRAY with any company

Follow XRAY

Get an email when DENTSPLY SIRONA Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when XRAY files with the SEC.

Where the numbers come from

Financial figures are the values DENTSPLY SIRONA Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.